Co-Infection Pneumonia with Mycobacterium abscessus and Pneumocystis jiroveci in a Patient without HIV Infection Diagnosed by Metagenomic Next-Generation Sequencing-Reference-Cited by-同舟云学术

Co-Infection Pneumonia with Mycobacterium abscessus and Pneumocystis jiroveci in a Patient without HIV Infection Diagnosed by Metagenomic Next-Generation Sequencing

Published:2021-03 Issue: Volume:Volume 14 Page:879-888
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Xie Dan^ORCID,Xian Ying,You Jingya,Xu Wen,Fan Min,Bi Xiaogang,Zhang Kouxing

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference24 articles.

1. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

2. First case report of chronic pulmonary lung disease caused by Mycobacterium abscessus in two immunocompetent patients in Saudi Arabia

3. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metagenomic next-generation sequencing promotes diagnosis and treatment of Pneumocystis jirovecii pneumonia in non-HIV infected children: a retrospective study;BMC Pulmonary Medicine;2024-07-12

2. Mycobacterium abscessus pulmonary disease presenting with spontaneous pneumomediastinum and subcutaneous emphysema in childhood acute lymphoblastic leukemia: a case report and literature review;BMC Pediatrics;2023-08-28

3. Lung Quantitative Computer Tomography Analysis for Non-HIV Associated Pneumocystis Pneumonia Assessment：An Observational Clinical Cohort Study;2023-04-27

4. Rare Co-Infection of the Lungs with EBV and Pneumocystis Carinii in a Patient with Kidney Cancer: a Case Report;Clinical Laboratory;2023

5. Metagenomic next-generation sequencing may assist diagnosis of cat-scratch disease;Frontiers in Cellular and Infection Microbiology;2022-09-16